Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,287,169 papers from all fields of science
Search
Sign In
Create Free Account
Cyclohexane
Known as:
hexamethylene
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Cyclohexane:MCnc:Pt:Bld:Qn
Cyclohexane:PrThr:Pt:Bld:Ord
hexahydroxybenzene
n-hexane
Broader (4)
Cyclohexanes
Cycloparaffins
Hexanes
cyclic compound
Narrower (3)
Ketamine
Venlafaxine hydrochloride
venlafaxine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Adsorption equilibrium of organic vapors on single-walled carbon nanotubes
S. Agnihotri
,
M. Rood
,
M. Rostam-Abadi
2005
Corpus ID: 53314825
Highly Cited
2003
Highly Cited
2003
Cyclohexane and benzene amination by catalytic nitrene insertion into C-H bonds with the copper-homoscorpionate catalyst TpBr3CuNCMe.
M. Díaz‐Requejo
,
T. Belderrain
,
M. Nicasio
,
S. Trofimenko
,
P. Pérez
Journal of the American Chemical Society
2003
Corpus ID: 39869970
The complex TpBr3Cu(NCMe) catalyzes, at room temperature, the insertion of a nitrene group from PhINTs into the carbon-hydrogen…
Expand
Highly Cited
1997
Highly Cited
1997
Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis
C. Preston
,
M. J. Nicholl
Journal of Virology
1997
Corpus ID: 20320758
Herpes simplex virus type 1 (HSV-1) mutants defective in immediate-early (IE) gene expression do not readily enter productive…
Expand
Highly Cited
1997
Highly Cited
1997
A simple synthesis of [11C]dihydrotetrabenazine (DTBZ).
D. Jewett
,
M. Kilbourn
,
Lihsueh C. Lee
Nuclear Medicine and Biology
1997
Corpus ID: 28544271
Highly Cited
1994
Highly Cited
1994
Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
Peter W. Andrews
,
Ivan Damjanov
,
+4 authors
K. Sampath
Laboratory investigation; a journal of technical…
1994
Corpus ID: 26102604
BACKGROUND Osteogenic protein-1 (OP-1) is a member of the transforming growth factor-beta super family closely related to the…
Expand
Review
1990
Review
1990
Pharmacodynamics in cancer therapy.
M. Ratain
,
R. Schilsky
,
B. A. Conley
,
M. J. Egorin
Journal of Clinical Oncology
1990
Corpus ID: 30151865
Our understanding of anticancer pharmacodynamics, and the relationships between pharmacologic measurements and clinical effects…
Expand
Highly Cited
1986
Highly Cited
1986
Actinacyclobutanes. Thermochemistry based strategies for the ring-opening stoichiometric activation of saturated and olefinic hydrocarbons.
C. M. Fendrick
,
T. Marks
Journal of the American Chemical Society
1986
Corpus ID: 207035774
Etude des reactions du dimethyl-3,3 di-η 5 -pentamethylcyclopentadienyl-1,1 thoracyclobutane avec des alcanes, le…
Expand
Highly Cited
1980
Highly Cited
1980
Polyamine biosynthesis enzymes in the induction and inhibition of differentiation in Friend erythroleukemia cells.
Y. Gazitt
,
C. Friend
Cancer Research
1980
Corpus ID: 16799146
O-Ornithine decarboxylase (ODC) activity in cultures of Friend erythroleukemia cells induced to differentiate with various…
Expand
Highly Cited
1979
Highly Cited
1979
Spermine and spermidine-induced B to A transition of DNA in solution.
E. Minyat
,
V. Ivanov
,
A. M. Kritzyn
,
L. Minchenkova
,
A. Schyolkina
Journal of Molecular Biology
1979
Corpus ID: 2848851
Highly Cited
1977
Highly Cited
1977
Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
E. Fibach
,
R. Reuben
,
R. Rifkind
,
P. Marks
Cancer Research
1977
Corpus ID: 12977548
Friend virus-transformed murine erythroleukemia cells express the program of erythropoietic differentiation under the influence…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required